FDABristol Myers SquibbEMAMedidatachronic lymphocytic leukemiaBreyanzismall lymphocytic lymphomaR/R B-ALLCLLCLL/SLL+1 more
…4;JCO 42:7047-7047. DOI:10.1200/JCO.2024.42.16_suppl.70472 U.S. FDA approves Bristol Myers Squibb’s 2. Breyanzi® as the first and o…